Kasia Koczula

Opinion author

Kasia Koczula, PhD, is an engagement manager at Lifescience Dynamics with over eight years of consulting experience in the life sciences sector. She holds a PhD in hematological oncology and has worked across a broad range of therapy areas, including oncology, cardiovascular diseases and rare diseases. Koczula specializes in competitive intelligence, market research and strategic advisory services, supporting clients with evidence-based insights to drive informed decision-making.

Opinion

The real potential of PD-(L)1×VEGF bispecifics may be outside lung cancer

PD-(L)1×VEGF bispecifics have emerged as a closely watched new class in immuno-oncology, with multiple candidates advancing through trials in lung cancer. But the potential of these drugs may be highest in cancers where angiogenesis and immune escape are tightly intertwined.

May 28, 2026

6 min read

Souro Chowdhury